Filing Details

Accession Number:
0001209191-16-115915
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-27 16:18:57
Reporting Period:
2016-04-25
Filing Date:
2016-04-27
Accepted Time:
2016-04-27 16:18:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1037760 Cepheid CPHD Laboratory Analytical Instruments (3826) 770441625
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189846 L John Bishop C/O Cepheid
904 Caribbean Drive
Sunnyvale CA 94089
Chairman Of The Board And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-04-25 110,000 $8.43 194,449 No 4 M Direct
Common Stock Disposition 2016-04-25 110,000 $35.50 84,449 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2016-04-25 110,000 $0.00 110,000 $8.43
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2016-04-25 150,000 $0.00 150,000 $35.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-04-28 2016-04-28 No 4 M Direct
150,000 2017-04-25 2023-04-25 No 4 A Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
  2. The sales price reported is the weighted average sale price for the number of shares sold. Full information regarding the number of shares sold at each separate price will be supplied upon request by the Securities & Exchange Commission staff, the Issuer or a security holder of the Issuer.
  3. 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.